Oneness Biotech Co., Ltd. (TPEX: 4743)
Taiwan
· Delayed Price · Currency is TWD 86.20
-1.20 (-1.37%)
Dec 20, 2024, 1:30 PM CST
Oneness Biotech Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 112.2 | 86.78 | 1,066 | 65.77 | 41.61 | 13.48 | Upgrade
|
| Revenue Growth (YoY) | 47.85% | -91.86% | 1520.24% | 58.07% | 208.76% | -28.54% | Upgrade
|
| Cost of Revenue | 49.12 | 54.22 | 221.16 | 20.72 | 10.89 | 17 | Upgrade
|
| Gross Profit | 63.08 | 32.56 | 844.39 | 45.04 | 30.72 | -3.53 | Upgrade
|
| Selling, General & Admin | 219.93 | 176.64 | 166.83 | 117.22 | 107.55 | 69.57 | Upgrade
|
| Research & Development | 979.95 | 952.55 | 919.02 | 805.96 | 589.28 | 238.64 | Upgrade
|
| Other Operating Expenses | 0.63 | - | - | - | 7.06 | - | Upgrade
|
| Operating Expenses | 1,201 | 1,129 | 1,086 | 923.18 | 703.89 | 308.21 | Upgrade
|
| Operating Income | -1,137 | -1,097 | -241.45 | -878.14 | -673.17 | -311.73 | Upgrade
|
| Interest Expense | -9.52 | -5.61 | -4.6 | -4.9 | -5.18 | -6.26 | Upgrade
|
| Interest & Investment Income | 300.33 | 289.39 | 57.51 | 34.75 | 17.64 | 6.68 | Upgrade
|
| Earnings From Equity Investments | -498.78 | -498.78 | 90.02 | 280.31 | 485.93 | -43.98 | Upgrade
|
| Currency Exchange Gain (Loss) | -133.16 | -12.97 | 544.67 | -151.29 | -67.18 | -3.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 203.23 | 7.08 | 8.68 | 12.01 | 4.62 | 2.93 | Upgrade
|
| EBT Excluding Unusual Items | -1,275 | -1,318 | 454.83 | -707.26 | -237.35 | -355.39 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.32 | -0.03 | -3.2 | 0.97 | -11.77 | 35.33 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.23 | 0.26 | - | - | - | -0 | Upgrade
|
| Asset Writedown | - | - | - | 6.19 | - | -6.19 | Upgrade
|
| Other Unusual Items | -1.51 | - | - | 304.13 | -0.82 | - | Upgrade
|
| Pretax Income | -1,277 | -1,317 | 451.63 | -395.96 | -249.94 | -326.26 | Upgrade
|
| Income Tax Expense | 2.8 | 5.29 | 99.73 | 16.86 | 1.74 | - | Upgrade
|
| Earnings From Continuing Operations | -1,280 | -1,323 | 351.9 | -412.82 | -251.68 | -326.26 | Upgrade
|
| Minority Interest in Earnings | 21.1 | 9.7 | 8.08 | 9.52 | 9.78 | 4.06 | Upgrade
|
| Net Income | -1,259 | -1,313 | 359.98 | -403.3 | -241.9 | -322.21 | Upgrade
|
| Net Income to Common | -1,259 | -1,313 | 359.98 | -403.3 | -241.9 | -322.21 | Upgrade
|
| Shares Outstanding (Basic) | 477 | 473 | 465 | 455 | 426 | 300 | Upgrade
|
| Shares Outstanding (Diluted) | 477 | 473 | 472 | 455 | 426 | 300 | Upgrade
|
| Shares Change (YoY) | 1.24% | 0.36% | 3.58% | 6.82% | 42.09% | 28.30% | Upgrade
|
| EPS (Basic) | -2.64 | -2.77 | 0.77 | -0.89 | -0.57 | -1.07 | Upgrade
|
| EPS (Diluted) | -2.64 | -2.77 | 0.76 | -0.89 | -0.57 | -1.07 | Upgrade
|
| Free Cash Flow | -415.44 | -512.23 | -968.35 | -384.24 | 113.32 | -257.71 | Upgrade
|
| Free Cash Flow Per Share | -0.87 | -1.08 | -2.05 | -0.84 | 0.27 | -0.86 | Upgrade
|
| Dividend Per Share | - | - | 0.084 | - | - | - | Upgrade
|
| Gross Margin | 56.22% | 37.52% | 79.24% | 68.49% | 73.83% | -26.17% | Upgrade
|
| Operating Margin | -1013.80% | -1263.64% | -22.66% | -1335.27% | -1618.01% | -2313.42% | Upgrade
|
| Profit Margin | -1121.83% | -1512.82% | 33.78% | -613.25% | -581.42% | -2391.14% | Upgrade
|
| Free Cash Flow Margin | -370.28% | -590.25% | -90.88% | -584.26% | 272.37% | -1912.52% | Upgrade
|
| EBITDA | -716.78 | -674.23 | 231.23 | -712.66 | -513.47 | -259.56 | Upgrade
|
| EBITDA Margin | - | - | 21.70% | - | - | - | Upgrade
|
| D&A For EBITDA | 420.65 | 422.4 | 472.68 | 165.48 | 159.7 | 52.18 | Upgrade
|
| EBIT | -1,137 | -1,097 | -241.45 | -878.14 | -673.17 | -311.73 | Upgrade
|
| EBIT Margin | - | - | -22.66% | - | - | - | Upgrade
|
| Effective Tax Rate | - | - | 22.08% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.